Google Finance: notícies i preu del fons d'inversió American Century Investments One Choice Portfolio®: Conservative Investor Class (AOCIX)

Pàgina d'iniciAOCIX • Fons d'inversió

American Century Investments One Choice Portfolio®: Conservative Investor Class

13,88 $

14 d’ag. · USD · MUTF · Exempció de responsabilitat

American Century Investments One Choice Portfolio®: Moderate Investor Class

16,49 $

AOMIX0,36 %

American Century Investments One Choice Portfolio®: Aggressive Investor Class

17,81 $

AOGIX0,39 %

American Century Investments One Choice Portfolio®: Very Aggressive Investor Class

21,73 $

AOVIX0,41 %

American Century Investments One Choice Portfolio®: Very Conservative Investor Class

11,88 $

AONIX0,25 %

American Century Investments One Choice 2045 Portfolio Investor Class

19,08 $

AROIX0,31 %

American Century Investments One Choice In Retirement Portfolio Investor Class

12,78 $

ARTOX0,16 %

American Century Investments One Choice 2035 Portfolio Investor Class

17,27 $

ARYIX0,29 %

American Century Value Fund Investor Class

8,36 $

TWVLX0,24 %

American Century Growth Fund Investor Class

63,23 $

TWCGX0,13 %

American Century Strategic Allocation: Moderate Fund Investor Class

6,93 $

TWSMX0,43 %

Fons d'inversió

Tancament anterior

13,92 $

Ingressos d'enguany

5,71 %

Proporció de despeses

0,81 %

Categoria

Cautious Allocation

Classificació de Morningstar

Actius nets

1082,53 M USD

Rendibilitat

2,84 %

Avançament

Data de creació

30 de set. 2004

Notícies dels mercats

Yahoo Finance

fa 3 hores

Stock market today: Dow, S&P 500, Nasdaq notch weekly wins as slew of data muddies rate-cut path

'It better be different this time': BofA's Hartnett says the S&P's price-to-book valuation is higher than dot-com bubble top

Trump says no agreement on ending Russia's war in Ukraine as Putin says there was an 'understanding'

AOL.com

fa 5 hores

Should You Buy the 3 Highest-Yielding Dividend Stocks in the S&P 500?

Dow Touches First Record High of the Year as UnitedHealth Group Stock Soars

The Business Journals

fa 3 hores

Predictive Oncology reports $2M loss in Q2, faces Nasdaq delisting and merger lawsuit